Tier 3 · Filer Universe

IGC Pharma, Inc.

IGC · NYSE American · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$0.26
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001326205
Liquidity rank
#5669
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$1.27M2025-03-310001185185-26-000941
Annual diluted EPS-0.092025-03-310001185185-26-000941
Quarterly revenue$317,000.002026-03-310001185185-26-001885
Quarterly diluted EPS-0.022026-03-310001185185-26-001885

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.061Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNYSE AmericanBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer

Provenance